Skip to content
lifestyle.recentlegalnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vivani Medical, Inc.
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
August 6, 2026
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
May 13, 2026